# Carbidopa and Levodopa

NDC: 46708-333
Generic name: Carbidopa and Levodopa
Labeler / Manufacturer: Alembic Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20190606

FDA application: ANDA210341

## Active ingredients

- CARBIDOPA: 50 mg/1
- LEVODOPA: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"46708-333"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=46708-333
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a85a56c5-44dd-41d4-ac1c-bdc4758406a4